Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 48, Issue , 2014, Pages 142-148

  Houenou, J ^a,b,c,d   d'Albis, M A ^a,b,c,e   Daban, C ^a,b,c   Hamdani, N ^a,b,c   Delavest, M ^b,f   Lepine, J P ^b,f   Vederine, F E ^a,c   Carde, S ^a,c   Lajnef, M ^a,b   Cabon, C ^g   Dickerson, F ^h   Yolken, R H ^h   Tamouza, R ⁱ   Poupon, C ^d   Leboyer, M ^a,b,c,e  

^a INSERM U955   (France)

^b FONDATION FONDAMENTAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d CEA SACLAY   (France)

^e FACULTÉ DE MÉDECINE   (France)

^f CNRS   (France)

^g GH Henri Mondor   (France)

^h Stanley Research Program   (United States)

ⁱ SAINT LOUIS HOSPITAL   (France)

Author keywords

Bipolar disorder; Cytomegalovirus; Hippocampus; Schizophrenia; Verbal memory

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; BRAIN SIZE; CALIFORNIA VERBAL LEARNING TEST; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; HIPPOCAMPUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; VERBAL MEMORY; VOLUMETRY;

BD; BIPOLAR DISORDER; CALIFORNIA VERBAL LEARNING TEST; CMV; CVLT; CVLT RECALL SCORE FOR LIST A; CVLT-RC-A; CYTOMEGALOVIRUS; HC; HEALTHY CONTROLS; HIPPOCAMPUS; MADRS; MONTGOMERY-ASBERG DEPRESSION SCALE; PANSS; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; VERBAL MEMORY; YMRS; YOUNG MANIA RATING SCALE;

ADULT; BIPOLAR DISORDER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; VERBAL LEARNING; VIRAL PROTEINS;

EID: 84886000142     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.09.003     Document Type: Article

References (77)

1. Adriano F., Caltagirone C., Spalletta G. Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 2012, 18:180-200.
2. Aiello A.E., Haan M., Blythe L., Moore K., Gonzalez J.M., Jagust W. The influence of latent viral infection on rate of cognitive decline over 4years. J Am Geriatr Soc 2006, 54:1046-1054.
3. Albrecht P., Torrey E.F., Boone E., Hicks J.T., Daniel N. Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet 1980, 2:769-772.
4. Alexander M.P., Stuss D.T., Fansabedian N. California Verbal Learning Test: performance by patients with focal frontal and non-frontal lesions. Brain 2003, 126:1493-1503.
5. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Wurzner R., et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005, 79:3675-3683.
6. Arai Y., Ishiwata M., Baba S., Kawasaki H., Kosugi I., Li R.Y., et al. Neuron-specific activation of murine cytomegalovirus early gene e1 promoter in transgenic mice. Am J Pathol 2003, 163:643-652.
7. Barnett E.M., Cassell M.D., Perlman S. Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 1993, 57:1007-1025.
8. Bora E., Yucel M., Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009, 113:1-20.
9. Bristow B.N., O'Keefe K.A., Shafir S.C., Sorvillo F.J. Congenital cytomegalovirus mortality in the United States, 1990-2006. PLoS Negl Trop Dis 2011, 5:e1140.
10. Cascella N.G., Testa S.M., Meyer S.M., Rao V.A., Diaz-Asper C.M., Pearlson G.D., et al. Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J Psychiatr Res 2008, 42:930-937.
11. Chepenik L.G., Wang F., Spencer L., Spann M., Kalmar J.H., Womer F., et al. Structure-function associations in hippocampus in bipolar disorder. Biol Psychol 2012, 90:18-22.
12. de Castro-Manglano P., Mechelli A., Soutullo C., Landecho I., Gimenez-Amaya J.M., Ortuno F., et al. Structural brain abnormalities in first-episode psychosis: differences between affective psychoses and schizophrenia and relationship to clinical outcome. Bipolar Disord 2011, 13:545-555.
13. Delis D.C., Freeland J., Kramer J.H., Kaplan E. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol 1988, 56:123-130.
14. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Ruslanova I., Yolken R.H. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry 2003, 60:466-472.
15. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Krivogorsky B., et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 2004, 55:588-593.
16. Dickerson F., Kirkpatrick B., Boronow J., Stallings C., Origoni A., Yolken R. Deficit schizophrenia: association with serum antibodies to cytomegalovirus. Schizophr Bull 2006, 32:396-400.
17. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Leister F., et al. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Bipolar Disord 2006, 8:124-132.
18. Doorduin J., de Vries E.F., Willemsen A.T., de Groot J.C., Dierckx R.A., Klein H.C. Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 2009, 50:1801-1807.
19. Ebdrup B.H., Skimminge A., Rasmussen H., Aggernaes B., Oranje B., Lublin H., et al. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol 2011, 14:69-82.
20. Elizabeth M. Family interview for genetic studies 1992, Clinical Neurogenetic Branch, Intramural Research Program, NIMH.
21. Fotheringham J., Donati D., Akhyani N., Fogdell-Hahn A., Vortmeyer A., Heiss J.D., et al. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med 2007, 4:e180.
22. Frey B.N., Andreazza A.C., Nery F.G., Martins M.R., Quevedo J., Soares J.C., et al. The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol 2007, 18:419-430.
23. Gaytant M.A., Steegers E.A., Semmekrot B.A., Merkus H.M., Galama J.M. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002, 57:245-256.
24. Gerber S.I., Krienke U.J., Biedermann N.C., Grunze H., Yolken R.H., Dittmann S., et al. Impaired functioning in euthymic patients with bipolar disorder-HSV-1 as a predictor. Prog Neuropsychopharmacol Biol Psychiatry 2012, 36:110-116.
25. Geuze E., Vermetten E., Bremner J.D. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry 2005, 10:160-184.
26. Hamdani N., Tamouza R., Leboyer M. Immuno-inflammatory markers of bipolar disorder: a review of evidence. Front Biosci (Elite Ed) 2012, 4:2170-2182.
27. Hausler M., Ramaekers V.T., Doenges M., Schweizer K., Ritter K., Schaade L. Neurological complications of acute and persistent Epstein-Barr virus infection in paediatric patients. J Med Virol 2002, 68:253-263.
28. Henson R.N., Shallice T., Dolan R.J. Right prefrontal cortex and episodic memory retrieval: a functional MRI test of the monitoring hypothesis. Brain 1999, 122(Pt 7):1367-1381.
29. Heun R., Freymann K., Erb M., Leube D.T., Jessen F., Kircher T.T., et al. Successful verbal retrieval in elderly subjects is related to concurrent hippocampal and posterior cingulate activation. Dement Geriatr Cogn Disord 2006, 22:165-172.
30. Hoffmann C., Grossman R., Bokov I., Lipitz S., Biegon A. Effect of cytomegalovirus infection on temporal lobe development in utero: quantitative MRI studies. Eur Neuropsychopharmacol 2010, 20:848-854.
31. Johnson S.C., Saykin A.J., Flashman L.A., McAllister T.W., Sparling M.B. Brain activation on fMRI and verbal memory ability: functional neuroanatomic correlates of CVLT performance. J Int Neuropsychol Soc 2001, 7:55-62.
32. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
33. Kenneson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17:253-276.
34. Kosugi I., Kawasaki H., Tsuchida T., Tsutsui Y. Cytomegalovirus infection inhibits the expression of N-methyl-D-aspartate receptors in the developing mouse hippocampus and primary neuronal cultures. Acta Neuropathol 2005, 109:475-482.
35. Kramer J.H., Rosen H.J., Du A.T., Schuff N., Hollnagel C., Weiner M.W., et al. Dissociations in hippocampal and frontal contributions to episodic memory performance. Neuropsychology 2005, 19:799-805.
36. Kremer S., Matern J.F., Bilger K., Lioure B., Fornecker Y., Stoll-Keller F., et al. EBV limbic encephalitis after allogenic hematopoietic stem cell transplantation. J Neuroradiol 2010, 37:189-191.
37. Lokensgard J.R., Cheeran M.C., Hu S., Gekker G., Peterson P.K. Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J Infect Dis 2002, 186(Suppl. 2):S171-S179.
38. Mansur R.B., Zugman A., Asevedo E.M., da Cunha G.R., Bressan R.A., Brietzke E. Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages. Psychiatry Clin Neurosci 2012, 66:247-260.
39. Marsland A.L., Petersen K.L., Sathanoori R., Muldoon M.F., Neumann S.A., Ryan C., et al. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom Med 2006, 68:895-903.
40. Marsland A.L., Gianaros P.J., Abramowitch S.M., Manuck S.B., Hariri A.R. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 2008, 64:484-490.
41. Mondelli V., Pariante C.M., Navari S., Aas M., D'Albenzio A., Di Forti M., et al. Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophr Res 2010, 119:75-78.
42. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
43. Moore G.J., Bebchuk J.M., Wilds I.B., Chen G., Manji H.K. Lithium-induced increase in human brain grey matter. Lancet 2000, 356:1241-1242.
44. Mucci A., Galderisi S., Kirkpatrick B., Bucci P., Volpe U., Merlotti E., et al. Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia. Schizophr Res 2007, 92:252-261.
45. Niehusmann P., Mittelstaedt T., Bien C.G., Drexler J.F., Grote A., Schoch S., et al. Presence of human herpes virus 6 DNA exclusively in temporal lobe epilepsy brain tissue of patients with history of encephalitis. Epilepsia 2010, 51:2478-2483.
46. Nugent A.C., Luckenbaugh D.A., Wood S.E., Bogers W., Zarate C.A., Drevets W.C. Automated subcortical segmentation using FIRST: test-retest reliability, interscanner reliability, and comparison to manual segmentation. Hum Brain Mapp 2012.
47. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994, 51:849-859. [discussion 863-844].
48. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011, 56:907-922.
49. Perron H., Bernard C., Bertrand J.B., Lang A.B.., Popa I., Sanhadji K., et al. Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis. J Neurol Sci 2009, 286:65-72.
50. Prasad K.M., Bamne M.N., Shirts B.H., Goradia D., Mannali V., Pancholi K.M., et al. Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia. Schizophr Res 2010, 118:232-239.
51. Prasad K.M., Eack S.M., Keshavan M.S., Yolken R.H., Iyengar S., Nimgaonkar V.L. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophr Bull 2012.
52. Prasad K.M., Watson A.M., Dickerson F.B., Yolken R.H., Nimgaonkar V.L. Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull 2012.
53. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
54. Reed J.M., Squire L.R. Impaired recognition memory in patients with lesions limited to the hippocampal formation. Behav Neurosci 1997, 111:667-675.
55. Rimon R., Ahokas A., Palo J. Serum and cerebrospinal fluid antibodies to cytomegalovirus in schizophrenia. Acta Psychiatr Scand 1986, 73:642-644.
56. Schleiss M.R. Cytomegalovirus vaccine development. Curr Top Microbiol Immunol 2008, 325:361-382.
57. Schretlen D.J., Vannorsdall T.D., Winicki J.M., Mushtaq Y., Hikida T., Sawa A., et al. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia. Schizophr Res 2010, 118:224-231.
58. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757.
59. Shinmura Y., Aiba-Masago S., Kosugi I., Li R.Y., Baba S., Tsutsui Y. Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus. Am J Pathol 1997, 151:1331-1340.
60. Shirts B.H., Prasad K.M., Pogue-Geile M.F., Dickerson F., Yolken R.H., Nimgaonkar V.L. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res 2008, 106:268-274.
61. Sowell E.R., Delis D., Stiles J., Jernigan T.L. Improved memory functioning and frontal lobe maturation between childhood and adolescence: a structural MRI study. J Int Neuropsychol Soc 2001, 7:312-322.
62. Staras S.A., Dollard S.C., Radford K.W., Flanders W.D., Pass R.F., Cannon M.J. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006, 43:1143-1151.
63. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., et al. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
64. Strasser H.C., Lilyestrom J., Ashby E.R., Honeycutt N.A., Schretlen D.J., Pulver A.E., et al. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study. Biol Psychiatry 2005, 57:633-639.
65. Tedla Y., Shibre T., Ali O., Tadele G., Woldeamanuel Y., Asrat D., et al. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J 2011, 49:211-220.
66. Tischler L., Brand S.R., Stavitsky K., Labinsky E., Newmark R., Grossman R., et al. The relationship between hippocampal volume and declarative memory in a population of combat veterans with and without PTSD. Ann N Y Acad Sci 2006, 1071:405-409.
67. Torrey E.F., Yolken R.H., Winfrey C.J. Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science 1982, 216:892-894.
68. Tsutsui Y. Effects of cytomegalovirus infection on embryogenesis and brain development. Congenit Anom (Kyoto) 2009, 49:47-55.
69. Tsutsui Y., Kosugi I., Kawasaki H. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev Med Virol 2005, 15:327-345.
70. van Erp T.G., Therman S., Pirkola T., Tuulio-Henriksson A., Glahn D.C., Bachman P., et al. Verbal recall and recognition in twins discordant for schizophrenia. Psychiatry Res 2008, 159:271-280.
71. van Norden A.G., de Laat K.F., Fick I., van Uden I.W., van Oudheusden L.J., Gons R.A., et al. Diffusion tensor imaging of the hippocampus and verbal memory performance: the RUN DMC study. Hum Brain Mapp 2012, 33:542-551.
72. Wais P.E., Wixted J.T., Hopkins R.O., Squire L.R. The hippocampus supports both the recollection and the familiarity components of recognition memory. Neuron 2006, 49:459-466.
73. Watson A.M., Prasad K.M., Klei L., Wood J.A., Yolken R.H., Gur R.C., et al. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med 2012, 1-9.
74. Yolken R.H., Torrey E.F. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 2008, 13:470-479.
75. Yolken R.H., Torrey E.F., Lieberman J.A., Yang S., Dickerson F.B. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res 2011, 128:61-65.
76. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
77. Ystad M., Eichele T., Lundervold A.J., Lundervold A. Subcortical functional connectivity and verbal episodic memory in healthy elderly-a resting state fMRI study. Neuroimage 2010, 52:379-388.